H

Humasis Co Ltd
KOSDAQ:205470

Watchlist Manager
Humasis Co Ltd
KOSDAQ:205470
Watchlist
Price: 1 684 KRW 3.63% Market Closed
Market Cap: 217.9B KRW
Have any thoughts about
Humasis Co Ltd?
Write Note
Humasis Co Ltd
/
Income Statement
/
Cost of Revenue

Humasis Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Humasis Co Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
H
Humasis Co Ltd
KOSDAQ:205470
Cost of Revenue
-₩40.9B
CAGR 3-Years
8%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
SD Biosensor Inc
KRX:137310
Cost of Revenue
-₩529.7B
CAGR 3-Years
14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
BioPlus Co Ltd
KOSDAQ:099430
Cost of Revenue
-₩25.5B
CAGR 3-Years
-48%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
H
HLB Inc
KOSDAQ:028300
Cost of Revenue
-₩44.2B
CAGR 3-Years
-1%
CAGR 5-Years
-7%
CAGR 10-Years
-11%
T
T&L Co Ltd
KOSDAQ:340570
Cost of Revenue
-₩70.3B
CAGR 3-Years
-41%
CAGR 5-Years
-35%
CAGR 10-Years
N/A
I
Interojo Co Ltd
KOSDAQ:119610
Cost of Revenue
-₩81.5B
CAGR 3-Years
-14%
CAGR 5-Years
-13%
CAGR 10-Years
-15%
No Stocks Found

Humasis Co Ltd
Glance View

Market Cap
217.9B KRW
Industry
Health Care

Humasis Co., Ltd. engages in developing rapid test kits and point-of-care testing instruments. The company is headquartered in Anyang, Gyeonggi-Do. The company went IPO on 2014-12-01. The firm is engaged in the manufacture and sale of immunoquantitative analysis devices, myocardial infarction test equipment, infectious disease detection devices, hormone test devices, cancer marker test devices and other products. In addition, the Company is engaged in the research and development of biomaterials and other products. The firm sells its products within domestic market and to overseas markets. The firm was established in 2000 and is located in Gunpo-si, Gyeonggi-do, South Korea.

Intrinsic Value
1 657.93 KRW
Overvaluation 2%
Intrinsic Value
Price
H
What is Intrinsic Value?

See Also

What is Humasis Co Ltd's Cost of Revenue?
Cost of Revenue
-40.9B KRW

Based on the financial report for Sep 30, 2024, Humasis Co Ltd's Cost of Revenue amounts to -40.9B KRW.

What is Humasis Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-51%

Over the last year, the Cost of Revenue growth was 34%. The average annual Cost of Revenue growth rates for Humasis Co Ltd have been 8% over the past three years , -51% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.